In this InSight Studio interview from SECO2019, we speak with Dr. Richard Madonna from SUNY Optometry, where he explains why hypertension is a risk factor for glaucoma. (surprisingly, the answer has part to do with hypotension!)

Registered ODwire.org members can discuss this video & ask Dr. Madonna questions in this thread

CooperVision has announced their Best Practices Honorees for 2019!

Now in it’s fourth year, the CooperVision Best Practices Program recognizes and celebrates practices in the U.S. that elevate the profession through innovation, industry leadership and patient experience.

In this ODwire TV episode, Dr. Michele Andrews, Senior Director of Professional & Academic Affairs at CooperVision announces the 2019 Best Practices honorees and talks about the genesis of the program.

Watch the video and discuss with your peers.

At SECO 2019, we got a first look at Alcon's new iLux MGD treatment.

(That's Gretchyn Bailey of Optometry Times asking all the questions & demoing the device!)

Its big calling-card is that it is substantially cheaper than alternative devices, while being therapeutically equivalent.

Read all about it in this thread, and discuss with your peers.

I'm happy to announce the launch of a new product (and a new ODwire.org site sponsor), the AB Max!

It is the latest instrument designed to treat anterior blepharitis.

I got a first-look at the devicee at SECO, and spoke with the device's inventor, John Choate.

The comparison with the BlephEx is natural and obvious (John was one of the designers of the original), the big differences that I could see:

1) the device has a patent-pending "pulse mode", which is more comfortable for the patients and...

2) the cost -- the device itself is billed as 1/3rd the cost, and the consumables (ie, the tips) are priced at about 50% of other devices.

They are running a SECO special including the device, tips, patient literature, an i-Chek and a cute little demodex mite toy to show to patients.

If you have any questions, post them in this thread, or visit their web site, www.AB-Max.com, or call them at 1-800-721-8006.

Discussion:
https://www.odwire.org/community/threads/ab-max-the-newest-instrument-for-treating-anterior-blepharitis.118919/

Refresh PM disappeared from store shelves last fall, much to the dismay of people with severe dry eye.

In this interview, we speak with Dave Gibson, Associate VP of Consumer Eyecare at Allergan and ask him:

* What happened?
* What alternatives are available?
* When will Refresh PM will be back on store shelves?!


ODwire.org members can comment in this thread.

CEwire2019 is coming! REGISTER HERE!

Over 9,000 ODs have chosen to participate in CEwire events over the past five years, and this year features our biggest roster of speakers and vendors yet.

Watch LIVE online on January 26th & 27th, or ON DEMAND at your own pace and on your own schedule through July 1st, 2019.

Visit the virtual exhibit hall to get exclusive discounts from leading vendors, and tune in to the CEwire2019 Livestream, where we'll chat with optometric thought leaders and eye care industry executives.

Learn more at https://www.cewire2019.com or REGISTER HERE. We look forward to seeing you at the event!


[READ MORE] [DISCUSS]

In this ODwire TV segment, we speak with Dr. Michele Andrews, Sr. Director of Professional & Academic Affairs at CooperVision about the science and clinical usefulness of the new Biofinity Energys contact lens.

Learn how the lens works, and which patients can best utilize it!

CooperVision is also offering free marketing materials to docs who want to Rx the lens.

Visit this site to order the materials for your patients.

All eye care practitioners are invited to log in and discuss here!

I'm happy to announce that Walman Instruments has opened a store in the ODwire.org Classifieds!

Here's a brief description of the company, for those who are unfamiliar:

Walman Instruments is a multi-line distributor of ophthalmic instrumentation that has been serving eye care professionals since 1915. We offer the finest products from more manufacturers than anyone in the industry. Our extensive selection enables our sales professionals to create custom designed solutions to meet the unique needs of your practice. We will exceed your expectations!

We have the largest showroom and training center in the U.S., and a multi-million dollar inventory. You can see the latest in diagnostic instruments before you buy, and get delivery when you need it. Our exclusive financing and trial programs are designed so that you can provide the best patient care, and stay within your budget.

Walman is proud to be a 100% employee-owned company. Our people own the company; our people make the difference. From eyewear, Rx and contact lens service to equipment sales and repair, Walman has a vested interest in ensuring your complete satisfaction and future success.

Check out the store & leave any questions for the company in this thread.

In this ODwire TV Episode, Drs. Jennifer Lyerly and William Townsend talk to us about the technology behind SYSTANE® COMPLETE.

We review the drop's mechanism of action, and why it gives effective dry eye relief, whether the etiology is evaporative, aqueous-deficient, or mixed.
All eye care practitioners are invited to log in and discuss here!

Last week  Nova Southeastern University’s (NSU) College of Optometry announced it has received a significant philanthropic gift from National Vision, Inc.

Subsequently, we learned that Nova was planning to change its name -- ostensibly to the "National Vision" College of Optometry.

This planned move has sparked controversy among university alums, to the point where over 2,000 have signed a petition to not change the school's name.  Many Nova students were also seen wearing black armbands at the recently completed Vision Expo West, in order to protest the move.

While corporate sponsorship is an increasingly common way to help fund academic institutions, one can see why this move has fallen afoul of some grads, as National Vision tends to downplay the role of the ECP in many of their ads:

What is your opinion about the situation?  ECPs can weigh in here.